(Q58204835)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

13 February 2020

main subject

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hideto Kameda

1 reference

ORCID Public Data File 2021

author name string

H Ogawa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

H Kameda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

K Amano

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

162-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Update on the management of lupus nephritis: let the treatment fit the patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Cyclosporin A: recent developments in the mechanism of action and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Ciclosporin in the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Effects of cyclosporine in severe systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Long-term treatment of lupus nephritis with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for Maintenance Therapy in Diffuse Lupus Nephritis over Four Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309350320

21 January 2018

Identifiers

DOI

10.1177/0961203309350320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19952069%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference